Purchase Order 36C24121P0717

This purchase order contract was awarded by the National Institutes of Health's National Institute of Child Health and Human Development to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the delivery of antibodies against HLA-DR labeled with APC-Cy7. Valued at approximately $6,901, the firm fixed price contract calls for the provision of ANTIBODIES: ANTI-HLA-DR APC-CY7 L243 (G46-6) RUO/GMP CATALOG# 335796 to the prime contractor's facility in Bethesda,...

Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, received a contract award from the National Institute of Neurological Disorders and Stroke on February 23, 2017, for a ceiling value of $3,465.00. This award is structured as a Blanket Purchase Agreement (BPA) call with firm fixed pricing and no small business set-aside designation. The work is to be performed in San Jose, California, with an ultimate completion date of December 20, 2021. As a leading medical...

Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, was awarded a $24.3K Blanket Purchase Agreement (BPA) call by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health. The contract, awarded on March 14, 2014, with an ultimate completion date of March 31, 2015, represents a Firm Fixed Price engagement with no small business set-aside designation. The work is to be performed in Bethesda, Maryland at...

The National Human Genome Research Institute issued a BPA call to The American Society of Human Genetics, Incorporated with a ceiling value of $1,118,255 and an award date of July 1, 2026. The call is issued under a single-award Blanket Purchase Agreement valued at $7,090,946 and effective May 1, 2023 through April 30, 2028. The parent BPA supports NIH Fellows Training Program services across the National Human Genome Research Institute's workforce development mission in human genetics and...

This contract award to Brainxell, Inc., a for-profit manufacturer of specialized human neuron cells, was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences. The $130,500.00 firm fixed-price purchase order includes the generation of a stable EGFP-expressing induced pluripotent stem cell (iPSC) line, differentiation of iPSCs into spinal motor neurons, and associated shipping services. This work supports...

Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a federal contract award valued at $24,263.88 from the National Institute of Neurological Disorders and Stroke (NINDS) on April 5, 2018. This Blanket Purchase Agreement (BPA) call, awarded on a firm fixed-price basis without small business set-aside designation, was completed by July 31, 2018, with performance executed in San Jose, California. BD Biosciences is a global medical technology company...

Brain Vision LLC was awarded a $84,334 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide unspecified products or services from August 14, 2014 through December 31, 2014. As the prime contractor, Brain Vision LLC will perform the work under this contract awarded through the Department of Health and Human Services. No additional details were provided regarding any subcontractors or the scope of work...

Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, received a $19,902.48 firm fixed-price contract award from the National Institute of Neurological Disorders and Stroke for chemicals and other materials. This Blanket Purchase Agreement (BPA) call was awarded on January 8, 2019, with an ultimate completion date of July 31, 2019. The contract was not set aside for small businesses and represents a child award under the parent entity Becton, Dickinson and Co....

The Department of Health and Human Services' National Institutes of Health National Institute of Mental Health awarded a $4,260 purchase order to Origene Technologies, Inc. of Bethesda, Maryland for DNA plasmids. The firm fixed price contract has a period of performance from September 21, 2016 through September 30, 2016. Origene will deliver the requested DNA plasmids to support the National Institute of Mental Health's biomedical research efforts aimed at better understanding mental...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $100,000.00 firm fixed-price purchase order contract to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of human cortical glutamatergic neurons to support research on neurological disease and SARS-CoV-2 infectivity. Brainxell, as a prime contractor, has previously received grant awards from...